Literature DB >> 12082617

Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.

Luigi Laghi1, Ombretta Orbetegli, Paolo Bianchi, Alessandro Zerbi, Valerio Di Carlo, C Richard Boland, Alberto Malesci.   

Abstract

Recent studies on small series of pancreatic cancer (PC) with foci of pancreatic intraepithelial neoplasia (PanIN), a putative precursor lesion, have shown that multiple K-RAS mutations may coexist in the same neoplastic pancreas. To see whether mutant-K-RAS polyclonality is a common and specific feature of pancreatic carcinogenesis, we investigated a unselected series of periampullary cancers (41 pancreatic, 13 biliary and two ampullary adenocarcinomas). After hemi-nested polymerase chain reaction (PCR), mutations identified with single strand conformation polymorphism (SSCP) were confirmed by allele-specific PCR and sequencing. K-RAS codon 12 was mutated in 34 (83%) pancreatic cancers and in 11 (85%) biliary cancers. Multiple distinct K-RAS mutations were found in 16 PC (39% of all cases, 47% of those with mutated K-RAS) and in eight biliary cancers (62 and 72%, respectively). In PC, multiple K-RAS mutations were more frequent (P<0.001) in cancers with (nine of 12, 75%) than in those without detectable PanIN (seven of 29, 24%). Individual precursor lesions of the same neoplastic pancreas were found to harbor distinct mutations. Results show that multiple K-RAS mutations are frequent both in PC with associated PanIN and in biliary cancers, and indicate that clonally distinct precursor lesions of PC might variably contribute to tumor development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082617     DOI: 10.1038/sj.onc.1205533

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma.

Authors:  Yong-Jun Chen; Qi-Bin Tang; Shen-Quan Zou
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

Review 2.  Developments in miRNA gene signaling pathways in pancreatic cancer.

Authors:  Christina Vorvis; Marina Koutsioumpa; Dimitrios Iliopoulos
Journal:  Future Oncol       Date:  2016-03-17       Impact factor: 3.404

3.  Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies.

Authors:  Ellen Weisberg; Atsushi Nonami; Zhao Chen; Feiyang Liu; Jianming Zhang; Martin Sattler; Erik Nelson; Kristen Cowens; Amanda L Christie; Constantine Mitsiades; Kwok-Kin Wong; Qingsong Liu; Nathanael Gray; James D Griffin
Journal:  Leukemia       Date:  2014-05-05       Impact factor: 11.528

Review 4.  Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).

Authors:  Jan-Bart M Koorstra; Georg Feldmann; Nils Habbe; Anirban Maitra
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

Review 5.  Clinical relevance of KRAS in human cancers.

Authors:  Sylwia Jancík; Jirí Drábek; Danuta Radzioch; Marián Hajdúch
Journal:  J Biomed Biotechnol       Date:  2010-06-07

6.  A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand.

Authors:  Qi Sun; Jason Phan; Anders R Friberg; DeMarco V Camper; Edward T Olejniczak; Stephen W Fesik
Journal:  J Biomol NMR       Date:  2014-08-03       Impact factor: 2.835

7.  Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology.

Authors:  Chanjuan Shi; Arjun Chandrasekaran; Paul J Thuluvath; Collins Karikari; Pedram Argani; Michael Goggins; Anirban Maitra; James R Eshleman
Journal:  J Mol Diagn       Date:  2009-10-08       Impact factor: 5.568

8.  Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.

Authors:  Qiong J Wang; Zhiya Yu; Kayla Griffith; Ken-ichi Hanada; Nicholas P Restifo; James C Yang
Journal:  Cancer Immunol Res       Date:  2015-12-23       Impact factor: 11.151

Review 9.  Molecular genetics of pancreatic intraepithelial neoplasia.

Authors:  Georg Feldmann; Robert Beaty; Ralph H Hruban; Anirban Maitra
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-05-29

10.  RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.

Authors:  Jimmy Y C Chow; Khai T Quach; Betty L Cabrera; Jennifer A Cabral; Stayce E Beck; John M Carethers
Journal:  Carcinogenesis       Date:  2007-07-17       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.